@article{10.25259/IJDVL_773_2021, title = {Coronavirus disease 2019 vaccination in patients with psoriasis: A position statement from India by SIG psoriasis (IADVL Academy)}, author = {Parthasaradhi, Anchala and Ganguly, Satyaki and Kar, Bikash Ranjan and Thomas, Jayakar and Neema, Shekhar and Tahiliani, Sushil and Sathishkumar, Dharshini and Parasramani, Shrichand G and Chalam, K Venkata and Komeravalli, Haritha}, abstract = { Coronavirus disease 2019 (COVID-19) pandemic has affected every sphere of life including management of psoriasis. The availability of COVID-19 vaccines has given rise to hope and at the same time some apprehensions as well. With the general population becoming eligible for vaccination, there is some confusion, on the eligibility of patients with different medical conditions and patients on immunosuppressive or immunomodulating medications for COVID-19 vaccination. Dermatologists treating psoriasis patients frequently face questions from them, whether they can undergo coronavirus disease 2019 vaccination. A PUBMED search was performed using the following strategy: ‘COVID-19’ AND ‘Vaccine’ AND ‘Psoriasis’. We also performed a PUBMED search using the following strategy: ‘SARS-CoV-2’ AND ‘Vaccine’ AND ‘Psoriasis’. All articles irrespective of language and publication date were included to arrive at this position statement. This position statement deals with the safety, eligibility and modifications of treatment, if needed among psoriasis patients with regards to the coronavirus disease 2019 vaccines currently available in India. }, volume = 88, journal = {Indian Journal of Dermatology, Venereology and Leprology}, issn = {0378-6323}, issn = {0973-3922}, url = {https://doi.org/10.25259/IJDVL_773_2021}, doi = {10.25259/IJDVL_773_2021} }